Home > Insider Trading > Filing (0001850902-22-000034)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1850902	Alpha Teknova Inc.	TKNO	In Vitro & In Vivo Diagnostic Substances (2835)	943368109

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1861134	Stephen Gunstream	C/O Alpha Teknova, Inc. 2451 Bert Drive Hollister CA 95023	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-05-13	1,292	$10.93	1,292	No	4	P	Direct
Common Stock	Acquisiton	2022-11-14	1,716	$4.23	61,008	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Acquisiton	2022-11-15	87,500	$0.00	87,500	$5.36

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
87,500		2032-11-15	No	4	A	Direct

Footnotes

The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Alpha Teknova, Inc. 2021 Employee Stock Purchase Plan (the ESPP), for the ESPP purchase period commencing on November 15, 2021, and ending on May 14, 2022 (the Prior Purchase Period). This transaction is also exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at the lesser of (i) 85% of fair market value on the first trading day of the Prior Purchase Period, and (ii) 85% of fair market value on the last day of the Prior Purchase Period, in each case rounded up to the nearest whole cent per share.
The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Alpha Teknova, Inc. 2021 Employee Stock Purchase Plan (the ESPP), for the ESPP purchase period commencing on May 15, 2022, and ending on November 14, 2022 (the Purchase Period). This transaction is also exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at the lesser of (i) 85% of fair market value on the first trading day of the Purchase Period, and (ii) 85% of fair market value on the last day of the Purchase Period, in each case rounded up to the nearest whole cent per share.
The number of shares subject to the option shall vest in 48 equal monthly installments on the same day of each month after November 15, 2022, the date of grant.